Table 1.
Summary of patient demographic and clinical information
Demographic and clinical details | ||
---|---|---|
Sex | M | 12 |
F | 2 | |
Age (years) | Range; median value | 28–71; 44.5 |
Country of birth | Italy | 7 |
Other countries* | 7 | |
No. of patients with extrahepatic (peritoneal and splenic) cysts | 1 | |
No. of patients with multiple hepatic cysts | 4 | |
Total number of cysts | 22 | |
No. of hepatic cysts | 18 surgically removed; two inactive cysts not removed | |
No. of extra-hepatic cysts | One surgically removed (splenic); one inactive peritoneal cyst not removed | |
Size of hepatic cysts | Range; median value (mm) | 25–160; 100 |
Location of surgically removed hepatic cysts | Left lobe (number of cysts) | 3 |
Right lobe (number of cysts) | 15 | |
No. of cysts per stage (WHO-IWGE) | CE3b | 13 (13 surgically removed) |
CE3a | 1 (one surgically removed) | |
CE4 | 8 (4 + 1† surgically removed) | |
No. of patients with previous treatments for CE | Albendazole alone | 8 |
Percutaneous | 1 | |
Surgery + albendazole | 1 | |
Percutaneous + albendazole | 2 | |
None | 2 | |
No. of patients with indication for surgery | Infection | 1 |
Cystobiliary fistula | 2 | |
Compression symptoms | 7 | |
Unresponsiveness to albendazole | 4 | |
No. of interventions per type | Marsupialization | 4 |
Pericystectomy | 8 + 1‡ | |
Lobectomy | 2 | |
No. of patients with postsurgical complications | Early (during hospitalization) | 2 |
Late (after discharge) | 1 | |
None | 11 |
CE = cystic echinococcosis; WHO-IWGE = World Health Organization Informal Working Group on Echinococcosis.
Other countries: Morocco (N = 3), Egypt (N = 1), Albania (N = 1), Macedonia (N = 1), and Moldova (N = 1).
Four CE4 cysts were hepatic, one splenic.
The patient with extra-hepatic cysts underwent a pericystectomy for the splenic cyst, and marsupialization for the liver cysts.